Cision PR Newswire

Asieris Pharmaceuticals Releases 2026 Semi-Annual Report: Core Product Commercialization Delivers, Entering a Harvest Period as the Company Accelerates Its Transition to Biopharma

SHANGHAI, Aug. 28, 2026 /PRNewswire/ -- Asieris Pharmaceuticals today released its 2026 Semi-Annual Report, showing comprehensive progress across all business segments. With the gradual realization of commercial launch and international expansion for its core products, the company is accelerating its transition from Biotech to Biopharma: CEVIRA®, the world's first...

INFOMEDIA TO ACQUIRE 50% OF INTELLEGAM – AN ENTREPRENEURIAL AUTOMOTIVE AI STARTUP IN EUROPE

SYDNEY, Feb. 14, 2025 /PRNewswire/ -- Infomedia Ltd (ASX: IFM) is pleased to announce that it has entered into a binding agreement to acquire...

ATFX Attends ACBC NSW Chinese New Year Gala 2025, Strengthening Australia-China Business Ties

SYDNEY, Feb. 14, 2025 /PRNewswire/ -- ATFX was honored to participate in the ACBC NSW Chinese New Year Gala 2025, a premier event that...

Zeekr Group Announces the Closing of Strategic Integrated Transactions

HANGZHOU, China, Feb. 14, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new...

YR Fitness Unveils the Secret to Successful Gym Layout Design

SHANGHAI, Feb. 14, 2025 /PRNewswire/ -- Success in the fitness industry goes beyond high-end equipment and expert trainers. According to YR Fitness, effective gym layout...

Notice convening the Annual General Meeting of AB Electrolux

STOCKHOLM, Feb. 14, 2025 /PRNewswire/ -- The shareholders of AB Electrolux (publ), reg. no. 556009-4178 (the "Company"), are hereby given notice of the Annual General...